Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prevention and treatment of post-operative pain and inflammation Condition: 0.1% concentration |
Dose: Ophthalmic drops – 1 drop Frequency: three times daily Duration: 1 day prior to cataract surgery, on the day of surgery, and through the first 2 weeks of the post-operative period |
|
Indication: Prevention and treatment of post-operative pain and inflammation Condition: 0.3% concentration |
Dose: Ophthalmic drops – 1 drop Frequency: once daily Duration: 1 day before cataract surgery, on day of surgery, and through the first 2 weeks postoperatively Note: An additional drop should be administered 30-120 minutes before surgery |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 10 years old |
Dose: Safety and efficacy not established Note: Safety and efficacy not established |
Administration
- Shake well before use
- One drop in affected eye(s)
Side Effect
- Capsular opacity
- Decr visual acuity
- Foreign body sensation
- Increased IOP
- Sticky sensation
- Conjunctival edema
- Corneal edema
- Dry eye
- Headache
- HTN
- Lid margin crusting
- N/V
- Ocular discomfort
- Ocular hyperemia
- Ocular pain
- Ocular pruritus
- Photophobia
- Tearing
- Vitreous detachment
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Topical NSAIDs (Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam, Indomethacin, Piroxicam, Ketorolac), Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone)
|
May increase risk of haemorrhage
|
|
Drugs that prolong bleeding time
|
May increase risk of haemorrhage
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.